Mariner Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
BFA
Mariner Investment Group's BMY Position: Q2 2016 in Review
Mariner Investment Group sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 83,700 shares — an estimated $5.35M sold.
Mariner Investment Group first reported a position in BMY in Q2 2015 and held it in 4 quarters. The position peaked at $5.35M in Q1 2016. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.
- Mariner Investment Group reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
- Mariner Investment Group sold 83,700 Bristol-Myers Squibb shares in Q2 2016, an estimated $5.35M.
- Mariner Investment Group first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 4 quarters.
- Mariner Investment Group's Bristol-Myers Squibb position peaked at $5.35M in Q1 2016.
- 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.
Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.